Cravens & Co Advisors, LLC
- SEC CIK
- 0001966116
- Latest filing
- Aug 12, 2026
PFE holding history
Pfizer Inc in every 13F filed by Cravens & Co Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −19,135−100.0% | Sold out | Holders |
| Q1 2024 | 19,135 | $531.0K | 0.4% | +1,681+9.6% | Added | Holders |
| Q4 2023 | 17,454 | $502.5K | 0.4% | −5,758−24.8% | Reduced | Holders |
| Q3 2023 | 23,212 | $770.0K | 0.7% | +1,620+7.5% | Added | Holders |
| Q2 2023 | 21,592 | $792.0K | 0.7% | −49−0.2% | Reduced | Holders |
| Q1 2023 | 21,641 | $882.9K | 0.8% | −87−0.4% | Reduced | Holders |
| Q4 2022 | 21,728 | $1.11M | 1.0% | – | No prior filing | Holders |